Articles tagged with T Cell Activation
B cells can activate themselves in autoimmune diseases without T cell assistance, leading to a 'vicious cycle' of chronic disease. This finding may explain why treatments targeting T cells have been less effective and newer B cell-targeted therapies show promise.
Researchers at Helmholtz Munich have found that ubiquitin attaches to Malt1 protein in T cells upon antigen stimulation, regulating immune defense. This process is reversible and helps prevent over-activation of T cells, a common cause of chronic diseases.
Researchers found that a viral protein helps monkeys resist AIDS symptoms, but HIV-1 lacks this protective function, leading to increased immune activation and disease progression. The study suggests that treatments mimicking the primate immune system might offer a new approach to HIV therapy.
Research reveals that human T cells lack expression of certain 'Siglec' molecules, which regulate T cell activation in nonhuman primates. This absence may contribute to the disparity in disease susceptibility between humans and great apes. The study highlights the potential for Siglecs to act as a 'brake' on T cell activation.
Scientists have discovered a specific signaling pathway, PKA, that is crucial for T-cell activation and immune function. In microgravity, this pathway fails to respond to pathogens, leading to severe T-cell suppression.
The study reveals that CD32a induces DC maturation, while CD32b inhibits it. This balance is crucial for generating immunity or tolerance. The findings also suggest a mechanism for intravenous immune globulin's anti-inflammatory properties.
Researchers describe the interaction between T-cell receptors and coreceptors during an immune response. They found that T-cell receptors and CD8 coreceptors are brought together during antigen sensing, increasing their interaction with endogenous non-stimulatory peptides.
A study challenges previous views on HIV-infected T cell lifespan, revealing that chronic immune activation drives high proliferation rates in memory T cells. HAART treatment improves long-lived T cell production, providing insight into the body's response to HIV infection.
Researchers discover that estrogen deficiency triggers immune system activation, leading to increased T cell proliferation and bone loss. This finding could lead to the development of new drugs that prevent postmenopausal bone loss without affecting reproductive organs.
Researchers have discovered that caspase-8 is essential for the activation of T-cells at the start of the immune response. The study found that inhibiting caspase-8 significantly decreases the immune response.
Researchers develop innovative approach to treating psoriasis using a novel combination of therapies and biomarkers, offering new hope for patients suffering from the chronic skin condition.
SLAP-130 protein plays a crucial role in bridging chemical pathways to activate T cells, generating an immune response. This discovery may lead to new treatments for cancers and autoimmune disorders by learning how to control T cell activation.
Researchers discovered HIV can replicate in resting T cells, previously thought to be uninfected. The virus spreads quickly through activated T cells as well, but these infected cells are harder to reach with current therapies.
Scientists have identified a correlation between activated CD44 and disease flare-ups in pediatric patients with lupus and rheumatoid arthritis. The study suggests that monitoring blood levels of activated CD44 may enable early prediction of exacerbations, potentially leading to improved treatment outcomes.
Scientists have identified SLP-76 as a critical protein for the development and activation of T cells, an essential part of the immune system. This finding provides valuable insights into the basic biology of immune system activation, which is crucial for understanding immunodeficiency disorders and autoimmune diseases.